Gupta, V. K. (2023) “Bimatoprost Ophthalmic Solution (BOS) 0.3 mg w/v for 1 Open Trial of Long-term Preventive Therapy of Migraine in 3 patients with Pathophysiologic Shift from Brain to Eye”, Journal of Neuroscience and Neurological Disorders, 7(2), pp. 134–154. doi: 10.29328/journal.jnnd.1001087.